LMG Life Sciences Awards EMEA 2023 shortlist revealed
Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX
Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2023 shortlist revealed

LMG-LS-2023-EMEA-logo-article

The LMG Life Sciences Awards is excited to announce its shortlist for the 2023 EMEA Awards.

The LMG Life Sciences Awards has released the full list of finalists for the 2023 EMEA awards.

The awards bring together Europe’s legal community to recognise the leading law firms and lawyers from across the region to celebrate their success in the Life Sciences industry.

Winners will be announced at the black-tie gala celebration which will be held on 13 July 2023 at the Waldorf Hilton.

A preview of the finalists can be found below and the full list of the finalists for all categories is available on the LMG Life Sciences website. The LMG Life Sciences Awards research team carefully selected each finalist after a thorough research period which included an analysis of direct submissions, client feedback, and much deliberation.

Individual practitioners and Rising Stars are judged not only on the complexity of the work the nominees completed in 2022, but also on their advocacy, influence, and thought leadership.

All of the work accepted for shortlisting closed during the research period, which was from January 1 to December 31 2022. The awards do not recognise cases, deals, or transactions completed outside of the research period.

If you have any questions regarding our research process, please contact our editor John Harrison

The LMG Life Sciences Awards will be announcing the winners on July 13 at a live awards gala. To find out more – and to find out about how you can promote your success – please contact Prin Shasiharan.

Preview of the LMG Life Sciences Awards EMEA 2023 shortlist:

  • Patent Litigation Firm of the Year: Biologics & Biosimilars

    Allen & Overy
    Carpmaels & Ransford
    DORDA
    Herbert Smith Freehills
    Pestalozzi Attorneys at Law
    Powell Gilbert
    Taylor Wessing
  • Patent Strategy & Management Firm of the Year

    Bird & Bird
    Deris Attorney at Law Partnership
    Dimitrov Petrov & Co
    Greenberg Traurig
    Kiortsis & Associates
    NSN Law Firm
    The Luzzatto Group
  • Patent Litigator of the Year: Biologics & Biosimilars

    Andreas Seling
    DORDA
    Andri Hess
    Homburger
    David Wilson
    Carpmaels & Ransford
    Emre Kerim Yardimci
    Deris Attorney at Law Partnership
    Laura Orlando
    Herbert Smith Freehills
    Patricia Cappuyns
    Taylor Wessing
    Zoe Butler
    Powell Gilbert

LMG Life Sciences is a sister publication to Managing IP, and is run independently from IP Stars research.



more from across site and ros bottom lb

More from across our site

Partners and other senior leaders must step up if they want diverse talent at their firms to thrive
European and US counsel reveal why they are (or aren't) concerned about patent quality and explain how external counsel can help
Firms such as Bird & Bird and Taylor Wessing have reported rising profits and highlighted the role of high-profile IP disputes and hires
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Lawyers in the corporate and IP practices discuss where the firm can steal a march on competitors, its growth plans in London, and why deal lawyers are ‘concertmasters’
Kathleen Gaynor, DEI specialist at Phillips Ormonde Fitzpatrick, says deliberate actions can help law firms reach diversity goals
Scott McKeown, who moved to Wolf Greenfield one year ago, says the change has helped him tap into life sciences work and advise more patent owners
The winners of our Asia-Pacific Awards 2024 will be revealed during a ceremony in Malaysia on September 26
Zach Piccolomini of Wolf Greenfield explains how to maximise your IP portfolio’s value while keeping an eye on competitors
Witnesses at a Congressional hearing debated whether reforming the ITC is necessary and considered what any changes should look like
Gift this article